Related Experiment Video
Updated: Sep 10, 2025

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity
Published on: November 2, 2020
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma
Margaret A Potts1,2,3, Shinsuke Mizutani1,2,4, Yexuan Deng1,2,3,5
1The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia.
Abstract:
Identifying tumor suppressor genes is predicted to inform on the development of novel strategies for cancer therapy. To identify new lymphoma driving processes that cooperate with oncogenic MYC, which is abnormally highly expressed in ~70% of human cancers, we use a genome-wide CRISPR gene knockout screen in Eµ-Myc;Cas9 transgenic hematopoietic stem and progenitor cells in vivo. We discover that loss of any of the GATOR1 complex components - NPRL3, DEPDC5, NPRL2 - significantly accelerates c-MYC-driven lymphoma development in mice. MYC-driven lymphomas lacking GATOR1 display constitutive mTOR pathway activation and are highly sensitive to mTOR inhibitors, both in vitro and in vivo. These findings identify GATOR1 suppression of mTORC1 as a tumor suppressive mechanism in MYC-driven lymphomagenesis and suggest an avenue for therapeutic intervention in GATOR1-deficient lymphomas through mTOR inhibition.
Insights
Loss of GATOR1 complex genes accelerates MYC-driven lymphoma by activating the mTOR pathway. This discovery suggests targeting mTOR could be a new therapy for GATOR1-deficient lymphomas.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Identifying tumor suppressor genes is crucial for developing novel cancer therapies.
- The MYC oncogene is highly expressed in many human cancers, driving tumorigenesis.
- Understanding cooperating genetic events with MYC is key to deciphering lymphoma development.
Purpose of the Study:
- To identify novel lymphoma-driving processes that cooperate with the oncogenic MYC.
- To explore the role of the GATOR1 complex in MYC-driven lymphomagenesis.
Main Methods:
- Genome-wide CRISPR gene knockout screen was performed in vivo.
- Utilized Eµ-Myc;Cas9 transgenic hematopoietic stem and progenitor cells.
- Assessed the impact of gene loss on lymphoma development and mTOR pathway activation.
Main Results:
- Loss of GATOR1 complex components (NPRL3, DEPDC5, NPRL2) significantly accelerates MYC-driven lymphoma in mice.
- MYC-driven lymphomas lacking GATOR1 exhibit constitutive mTOR pathway activation.
- These lymphomas are highly sensitive to mTOR inhibitors in vitro and in vivo.
Conclusions:
- GATOR1 complex suppresses mTORC1, acting as a tumor suppressor in MYC-driven lymphomagenesis.
- GATOR1 deficiency in lymphomas creates a therapeutic vulnerability to mTOR inhibitors.
- Targeting the mTOR pathway presents a potential therapeutic strategy for GATOR1-deficient lymphomas.
More Related Videos
07:37Performing an In Vitro Genome-Wide CRISPR Knockout Screen in Chimeric Antigen Receptor T Cells
Published on: January 31, 2025
07:01Evaluation of Abnormal Growth-related Genes of Hematopoietic Stem and Progenitor Cells by Combining CRISPR/Cas9 Technology with Cell Counting
Published on: May 2, 2025
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...